Cipla USA has recalled over 400 cartons of Nilotinib Capsules used to treat blood cancers after they failed to meet specifications, according to the U.S. Food and Drug Administration, which classified ...

Cipla USA has recalled unexpired batches of Lanreotide Injection, resulting in a temporary market shortage. The recall ...

Cipla Limited has announced that it has entered into a 60:40 joint venture agreement with Kemwell Biopharma Private Limited ...

Cipla USA, a subsidiary of the Indian drugmaker, is recalling over 400 cartons of generic anti-cancer drug Nilotinib due to a manufacturing issue. The recall is classified as Class III by the USFDA, ...

Cipla share price fell 2.4 per cent to the day's low of ₹1,335.90 per share on the National Stock Exchange (NSE) ...

More than 400 cartons of Nilotinib capsules were voluntarily recalled by Cipla USA after failing manufacturing specifications ...

After hitting Indian IT majors with the H-1B visa fee hike, US President Donald Trump has now lobbed a pharma grenade by imposing 100% tariffs on branded and patented drugs starting October 1. While ...

With many diabetes mellitus (DM) patients struggling with the challenges of multiple daily insulin injections, there is a growing need for convenient and needle-free insulin delivery ...

BANGALORE, July 29 (Reuters) - India's Sun Pharmaceutical Industries Ltd posted a sharp plunge in quarterly net profit on Wednesday, weighed down by the recent seizure of its unit's medicines by the U ...

Pharma stocks have made a big comeback in recent months, with companies such as Granules India, Gland Pharma, Dr. Reddy's Laboratories, Natco Pharma, Aurobindo Pharma, and Cipla rebounding sharply ...

Cipla Ltd. and Cipla USA were hit with a patent infringement lawsuit on Oct. 7 in Delaware District Court over their abbreviated new drug application for calcium gluconate injection products. The ...